Matches in Nanopublications for { ?s ?p "[Despite a well-established role of MGMT aberrations in carcinogenesis, neither MGMT promoter methylation nor MGMT loss serves as a prognostic biomarker in colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- NP426839.RA66-r1J4T2p-gMmcwCEEUxrOQewqHfvJ-N8AEWKqBxhA130_assertion description "[Despite a well-established role of MGMT aberrations in carcinogenesis, neither MGMT promoter methylation nor MGMT loss serves as a prognostic biomarker in colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP426839.RA66-r1J4T2p-gMmcwCEEUxrOQewqHfvJ-N8AEWKqBxhA130_provenance.
- NP585313.RAQBWl2mxqyKjpUAK9x-8gi-ntgFfAjqRlhA-X8XvNyBA130_assertion description "[Despite a well-established role of MGMT aberrations in carcinogenesis, neither MGMT promoter methylation nor MGMT loss serves as a prognostic biomarker in colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP585313.RAQBWl2mxqyKjpUAK9x-8gi-ntgFfAjqRlhA-X8XvNyBA130_provenance.
- assertion description "[Despite a well-established role of MGMT aberrations in carcinogenesis, neither MGMT promoter methylation nor MGMT loss serves as a prognostic biomarker in colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP857548.RAAdMfQ5gyIN0cInOIg9MctfYy93mZDtRVTje9xv-SwB0130_assertion description "[Despite a well-established role of MGMT aberrations in carcinogenesis, neither MGMT promoter methylation nor MGMT loss serves as a prognostic biomarker in colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857548.RAAdMfQ5gyIN0cInOIg9MctfYy93mZDtRVTje9xv-SwB0130_provenance.
- NP857547.RAFqtQJgC7_3-qBPFfhMDt9ZJxHE0-cp7s2pxGZlKfIW4130_assertion description "[Despite a well-established role of MGMT aberrations in carcinogenesis, neither MGMT promoter methylation nor MGMT loss serves as a prognostic biomarker in colorectal cancer.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP857547.RAFqtQJgC7_3-qBPFfhMDt9ZJxHE0-cp7s2pxGZlKfIW4130_provenance.